Oral Administration of Bacillus toyonensis Strain SAU-20 Improves Insulin Resistance and Ameliorates Hepatic Steatosis in Type 2 Diabetic Mice

In this study, the ameliorative effects of Bacillus toyonensis-SAU-20 (B. toyo SAU-20), a new probiotic strain isolated and identified by our laboratory from Ageratina adenophora, on the development of insulin resistance and hepatic steatosis in type 2 diabetic (T2DM) mice was investigated. Thirty S...

Descripción completa

Detalles Bibliográficos
Autores principales: Ren, Zhihua, Okyere, Samuel Kumi, Xie, Lei, Wen, Juan, Wang, Jiayi, Chen, Zhengli, Ni, Xueqin, Deng, Junliang, Hu, Yanchun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8887768/
https://www.ncbi.nlm.nih.gov/pubmed/35242140
http://dx.doi.org/10.3389/fimmu.2022.837237

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8887768/
https://www.ncbi.nlm.nih.gov/pubmed/35242140
http://dx.doi.org/10.3389/fimmu.2022.837237

Ejemplares similares